$ Value
$0
Shares
7,394
Price
$0
Filed
Sep 17
Insider
Name
Rojkjaer Lisa
Title
EVP, Chief Medical Officer
CIK
0001846460
Roles
Transaction Details
Transaction Date
2025-09-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,394
Footnotes
The Reporting Person was granted a stock option with a performance-based condition with respect to 7,394 shares of the Issuer's common stock on January 29, 2025. The exercise price of this option is $22.49, which is the closing price of the Issuer's common stock on Nasdaq on the date of grant. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On September 15, 2025, it was determined that the performance metric had been met. | The option was fully vested on September 15, 2025, the date the determination was made that the performance metric had been met.
Filing Info
Rojkjaer Lisa's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | RIGL | A | $0 |
| 2026-02-10 | RIGL | F | $130K |
| 2025-09-15 | RIGL | A | $0 |
Other Insiders at RIGL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MOOS WALTER H | — | $145K | 2026-02-20 |
|
RODRIGUEZ RAUL R
CEO, President
|
— | — | 2026-02-17 |
| MILLER MICHAEL PATRICK | — | — | 2026-02-01 |
|
Schorno Dean L
EVP & Chief Financial Officer
|
— | — | 2026-02-17 |
|
Furey Raymond J.
EVP, GC, CCO & Corp Sec
|
— | — | 2026-02-17 |
|
Santos David A
EVP, Chief Commercial Officer
|
— | — | 2026-02-17 |
|
Rojkjaer Lisa
EVP, Chief Medical Officer
|
— | — | 2026-02-17 |